Journal of Clinical Oncology

Vol. 44, Issue 19_suppl Issue 19_suppl 2026
340
Articles

Articles in this Issue

Blinded <sup>18</sup> FDG PET-CT re-read versus EBUS-TBNA in stage III <sub>A-C</sub> NSCLC: A mediastinal staging concordance study.

Kratika Bhatia, Manoj Gupta, Aman Gupta et al. Jul 01, 2026 pp. 280-280 10.1200/jco.2026.44.19_suppl.280

280 Background: 18 FDG PET-CT is standard for mediastinal staging of NSCLC, but its specificity is low...

An oral anlotinib-capecitabine regimen plus penpulimab as first-line therapy for recurrent/metastatic nasopharyngeal carcinoma (R/M NPC): A multicenter, single-arm, phase 2 clinical trial.

Cheng Xu, Song Qu, Zhigang Liu et al. Jul 01, 2026 pp. 227-227 10.1200/jco.2026.44.19_suppl.227

227 Background: Patients with NPC who progress after radical therapy often have poor prognosis and limited tolerance. Addi...

A study of quality of life and unmet needs in young adult cancer.

Disha Sawhney, Christopher G. Cann Jul 01, 2026 pp. 320-320 10.1200/jco.2026.44.19_suppl.320

320 Background: The global rise in cancer among young adults (AYAs) has shifted the focus of oncology from acute treatment...

Impact of smoking status on the efficacy of first-line immune checkpoint inhibitors in Asian patients with advanced non-small cell lung cancer: A meta-analysis.

Raghda Mateen, Aditya Anand, Nikhil Verma et al. Jul 01, 2026 pp. 273-273 10.1200/jco.2026.44.19_suppl.273

273 Background: Smoking is associated with higher tumor mutational burden and improved responsiveness to immune checkpoint...

The impact of vertebral body irradiation techniques on dose distribution to cardiac substructure during craniospinal irradiation for pediatric medulloblastoma: A detailed dosimetric study.

Huanzi Jiang Jul 01, 2026 pp. 72-72 10.1200/jco.2026.44.19_suppl.72

72 Background: With improved long-term survival in pediatric medulloblastoma, radiotherapy-related cardiac toxicity—partic...

Clinically actionable cancer and non-cancer risk genes identified by whole genome sequencing (WGS) in early-onset tumours (EOT).

Milita Zaheed, Brandon Signal, Kosar Hooshmand et al. Jul 01, 2026 pp. 170-170 10.1200/jco.2026.44.19_suppl.170

170 Background: The global incidence of EOT (≤40 years) is increasing, with no clear explanation. The short interval betwe...

Comparative efficacy and safety of sacituzumab govitecan versus chemotherapy in metastatic breast cancer: An updated meta-analysis and systematic review.

Mohammad Dawar Zahid, Mazhar Ali, Muhammad Atif Mazhar et al. Jul 01, 2026 pp. 30-30 10.1200/jco.2026.44.19_suppl.30

30 Background: Sacituzumab Govitecan (SG) is a Trop-2–directed antibody–drug conjugate with demonstrated survival benefit...

Effect of the FGF1-B promoter on spontaneous beta-cell tumorigenesis in F1B-Tag mice: A robust translational model for insulinoma and metabolic crosstalk.

Nai-Xin Gu, Po-Lin Lin, Yu-Ru Guo et al. Jul 01, 2026 pp. 153-153 10.1200/jco.2026.44.19_suppl.153

153 Background: Fibroblast growth factor 1 (FGF1) is a key regulator of glucose homeostasis and β-cell physiology. The F1B...

Clinical significance of germline <i>BRCA</i> pathogenic variants undetectable by comprehensive genomic profiling.

Shiho Hakui, Chigusa Morizane, Yuno Goto et al. Jul 01, 2026 pp. 161-161 10.1200/jco.2026.44.19_suppl.161

161 Background: BRACAnaylsis in Japan is widely used as a companion diagnostic for PARP inhibitors in multiple can...

Impact of SPECT/CT lymphoscintigraphy-based radiotherapy planning for reducing incidental dose to arm draining lymph nodal region vs standard planning on lymphedema incidence in early breast cancer patients post BCS: A double blind randomized controlled trial.

Aashish Joshy, Gunaseelan Karunanithi, Madhusudhanan P. et al. Jul 01, 2026 10.1200/jco.2026.44.19_suppl.tps67

TPS67 Background: Breast cancer-related lymphedema (BCRL) affects approximately 20-25% of patients after breast-conserving...

Inflammatory biomarker-based prognostic model for immunotherapy outcomes in patients with recurrent or metastatic cervical cancer.

Yulu Wang, Jing Li, Haifeng Qiu et al. Jul 01, 2026 pp. 210-210 10.1200/jco.2026.44.19_suppl.210

210 Background: Conventional predictive biomarkers, including programmed death ligand-1 (PD-L1) expression and tumor mutat...

Synergistic oncogenesis in human cholangiocytes: IDH1 mutation and the biliary microenvironment to drive early transformation and a targetable metabolic dependency in patient-derived organoids.

Ziye Chen, Qingru Song, Jinxin Wang et al. Jul 01, 2026 pp. 308-308 10.1200/jco.2026.44.19_suppl.308

308 Background: Cholangiocarcinoma (CCA) is a lethal malignancy with limited understanding of its early developmental mech...

Real-world outcomes and prognostic role of neutrophil-to-lymphocyte ratio (NLR) in patients with advanced urothelial carcinoma treated with enfortumab vedotin plus pembrolizumab (EVP).

Samad Sayed, Rishikesh Kumar, Martin Zarba et al. Jul 01, 2026 pp. 187-187 10.1200/jco.2026.44.19_suppl.187

187 Background: EVP has demonstrated a significant survival benefit in advanced urothelial carcinoma (aUC) in clinical tri...

Automation of OncoKB annotation to enhance efficiency and consistency of molecular tumor board workflows.

Zit Liang Chan, Kenneth Shiu Kahn Chow, Su Fen Ang et al. Jul 01, 2026 pp. 26-26 10.1200/jco.2026.44.19_suppl.26

26 Background: Molecular Tumor Boards (MTBs) play a critical role in translating next-generation sequencing (NGS) results...

Nodal status–guided postoperative radiotherapy after neoadjuvant chemoimmunotherapy for locally advanced esophageal squamous cell carcinoma: A multicenter cohort study.

Jinjie Li, Xinji Liu, Wei Ping et al. Jul 01, 2026 pp. 112-112 10.1200/jco.2026.44.19_suppl.112

112 Background: In locally advanced esophageal squamous cell carcinoma (ESCC) treated with neoadjuvant chemoimmunotherapy...

Potential overtreatment in MRI-defined low-risk locally advanced rectal cancer in the era of neoadjuvant therapy: An international cohort study.

Ryosuke Okamura, Seung Ho Song, Yuki Aisu et al. Jul 01, 2026 pp. 118-118 10.1200/jco.2026.44.19_suppl.118

118 Background: Multimodal neoadjuvant therapy, including chemoradiotherapy (CRT) and total neoadjuvant therapy, is the st...

Circadian rhythm of mortality among hospitalized cancer patients: A retrospective study.

Meimei Shang, Yingtao Meng, Yuping Liu Jul 01, 2026 pp. 340-340 10.1200/jco.2026.44.19_suppl.340

340 Background: Circadian rhythms are intrinsic 24-hour biological cycles that regulate numerous physiological processes....

Spatial multi-omics analyses to reveal KRT5 <sup>+</sup> tumor cell orchestration of an immune-excluded microenvironment in thymic carcinoma.

Yixiang Zhang, Qing Zhang, Zhao Wang et al. Jul 01, 2026 pp. 298-298 10.1200/jco.2026.44.19_suppl.298

298 Background: Thymic carcinoma is a rare and aggressive malignancy with limited therapeutic strategies and poor clinical...

A comparative analysis of frontier large language model (LLM) performance on standardized knowledge assessments and real world scenarios in genitourinary (GU) malignancies.

Sameer S. Deshmukh, Aaqid Syed, Oluwatayo Adeoye et al. Jul 01, 2026 pp. 21-21 10.1200/jco.2026.44.19_suppl.21

21 Background: Large language models (LLMs) are becoming an increasing source of medical information for both patients and...

Endothelial glycocalyx disruption to promote colorectal carcinogenesis and recurrence through formation of TLS-deficient immune microenvironment.

Masahide Endo, Hiroyuki Tomita, Seito Fujibayashi et al. Jul 01, 2026 pp. 148-148 10.1200/jco.2026.44.19_suppl.148

148 Background: The endothelial glycocalyx is a glycan-rich layer covering vascular endothelial cells and plays an essenti...

Comparison of double lung versus single lung ventilation in prone thoracoscopic esophagectomy for esophageal cancer: A multicenter cohort study.

Jayanth Yoganathan, Sampath Hirantha Herath, Jayamal Chaminda Ariyaratne Jul 01, 2026 pp. 355-355 10.1200/jco.2026.44.19_suppl.355

355 Background: Single lung ventilation (SLV) is conventionally used during thoracoscopic esophagectomy for esophageal can...

Functional outcomes and quality of life after partial glossectomy for tongue carcinoma: A prospective observational study.

Gautam Anand, Pawan Gupta, Chirag Jain et al. Jul 01, 2026 pp. 237-237 10.1200/jco.2026.44.19_suppl.237

237 Background: Tongue resection for carcinoma significantly impacts essential functions such as speech, swallowing, and t...

Patient, caregiver and provider perspectives on cancer treatment adherence in Singapore: A qualitative study.

Chin-Wen Chong, Xin Hui Chong, Hui Miao et al. Jul 01, 2026 pp. 332-332 10.1200/jco.2026.44.19_suppl.332

332 Background: Breast and colorectal cancers remain among the most prevalent in Singapore. Adherence to prescribed therap...

Treatment outcomes with first-line EGFR tyrosine kinase inhibitors in Vietnamese metastatic NSCLC patients harboring compound EGFR mutations.

Hoang Bao Ngoc, Kien Hung Do, Do Mai Linh et al. Jul 01, 2026 pp. 288-288 10.1200/jco.2026.44.19_suppl.288

288 Background: Compound EGFR mutations represent a heterogeneous group of genetic alterations with inferior clinical outc...

A ferroptosis-suppressive tumor state to drive chemoradiotherapy resistance and define a therapeutic vulnerability in muscle-invasive bladder cancer.

Takuya Tsujino, Shogo Yamazaki, Tomoaki Takai et al. Jul 01, 2026 pp. 195-195 10.1200/jco.2026.44.19_suppl.195

195 Background: Bladder-preserving chemoradiotherapy (CRT) is a curative alternative to radical cystectomy for muscle-inva...

All Issues

Journal Info

Publisher Lippincott Williams & Wilkins
ISSN 0732-183X
E-ISSN 1527-7755
Subject Health Sciences
Language English
View Full Journal Page